Organic Letters
Letter
Notes
Scheme 2. Possible Reaction Mechanism
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
We would like to thank the Ministry of Education of China
(IRT1225), the National Natural Science Foundation of China
(21362002, 41206077, and 81260472), Guangxi Natural Science
Foundation of China (2012GXNSFAA053027 and
2011GXNSFD018010), Guangxi Scientific Research and Tech-
nology Development Program (1355004-3), and Bagui Scholar
Program of Guangxi for financial support.
REFERENCES
■
(1) (a) Ocampo, R.; Dolbier, W. R., Jr. Tetrahedron 2004, 60, 9325.
(b) Hannick, S. M.; Kishi, Y. J. Org. Chem. 1983, 48, 3833. (c) Morelli, C.
F.; Manferdini, M.; Veronese, A. C. Tetrahedron 1999, 55, 10803.
(d) Mauduit, M.; Kouklovsky, C.; Langlois, Y.; Riche, C. Org. Lett. 2000,
2, 1053. (e) Bao, Y.-H.; Zhu, J.-Y.; Qin, W.-B.; Kong, Y.-B.; Chen, Z.-W.;
Tang, S.-B.; Liu, L.-X. Org. Biomol. Chem. 2013, 11, 7938. (f) Xu, M.;
Zhu, J.; Diao, Y.; Zhou, H.; Ren, X.; Sun, D.; Huang, J.; Han, D.; Zhao,
Z.; Zhu, L.; Xu, Y.; Li, H. J. Med. Chem. 2013, 56, 7911.
(2) (a) Chun, Y. S.; Lee, K. K.; Ko, Y. O.; Shin, H.; Lee, S.-g. Chem.
Commun. 2008, 5098. (b) Ko, Y. O.; Chun, Y. S.; Park, C.-L.; Kim, Y.;
Shin, H.; Ahn, S.; Hong, J.; Lee, S.-g. Org. Biomol. Chem. 2009, 7, 1132.
(3) (a) Cimarelli, C.; Palmieri, G. J. Org. Chem. 1996, 61, 5557.
Scheme 3. Isolated Intermediates 10, Rearrangement of 10
with Benzyl Azide, and Related Control Experiment
(b) Luhr, S.; Holz, J.; Zayas, O.; Wendisch, V.; Borner, A. Tetrahedron
̈
̈
2012, 23, 1301. (c) Jones, S.; Li, X. Tetrahedron 2012, 68, 5522.
(4) (a) Kaller, M. R.; Zhong, W.; Henley, C.; Magal, E.; Nguyen, T.;
Powers, D.; Rzasa, R. M.; Wang, W.; Xiong, X.; Norman, M. H. Bioorg.
Med. Chem. Lett. 2009, 19, 6591. For other synthetic methods, see:
(b) Veith, U. Process for preparing 2-amino-4-(4-fluorophenyl)-6-
alkylpyrimidine-5-carboxylates. US patent 6579984B1, Jun 17, 2003.
(c) Gerritz, S.; Shi, S.; Zhu, S. Aminoacetamide acyl guanidines as β-
secretase inhibitors and their preparation, pharmaceutical compositions,
and use in the treatment of neurological disorders. US patent
7273882B2, Sep 25, 2007. For good control over the E/Z ratio of β-
enaminoketoesters, see: (d) Shcherbakov, K. V.; Burgart, Ya. V.;
Saloutin, V. I. Russ. J. Org. Chem. 2013, 49, 719. (e) Ghabraie, E.;
Bararjanian, M.; Balalaie, S.; Rominger, F.; Bijanzadeh, H. R. Helv. Chim.
Acta 2011, 94, 1440.
(5) Huisgen, R. In 1,3-Dipolar Cycloaddition Chemistry; Padwa, A, Ed.;
Wiley Interscience: New York, 1984.
(6) (a) Jin, T.; Kamijo, S.; Yamamoto, Y. Eur. J. Org. Chem. 2004, 18,
3789. (b) Rohrig, U. F.; Majjigapu, S. R.; Grosdidier, A.; Bron, S.;
̈
Stroobant, V.; Pilotte, L.; Colau, D.; Vogel, P.; Eynde, B. J. V. d.; Zoete,
V.; Michielin, O. J. Med. Chem. 2012, 55, 5270. (c) Kumar, A. S.; Ghule,
V. D.; Subrahmanyam, S.; Sahoo, A. K. Chem.Eur. J. 2013, 19, 509.
(7) (a) Wang, Y.-C.; Xie, Y.-Y.; Qu, H.-E.; Wang, H.-S.; Pan, Y.-M.;
Huang, F.-P. J. Org. Chem. 2014, 79, 4463. (b) Molander, G. A.; Bibeau,
C. T. Tetrahedron Lett. 2002, 43, 5385. (c) Merling, E.; Lamm, V.; Geib,
S. J.; Laco
̂
te, E.; Curran, D. P. Org. Lett. 2012, 14, 2690. (d) Tukada, H.
Org. Lett. 2001, 3, 3261. (e) Troyer, T. L.; Muchalski, H.; Hong, K. B.;
yields. The mild, straightforward experimental condition should
prove valuable in both academic and industrial research settings.
Johnston, J. N. Org. Lett. 2011, 13, 1790. (f) Mloston
Heimgartner, H. Helv. Chim. Acta 2002, 85, 2056.
(8) Schmidt, K. F. Z. Angew. Chem. 1923, 36, 511.
́
, G.; Urbaniak, K.;
ASSOCIATED CONTENT
* Supporting Information
■
́
(9) (a) Gracias, V.; Frank, K. E.; Milligan, G. L.; Aube, J. Tetrahedron
S
1997, 53, 16241. (b) Chakraborty, R.; Franz, V.; Bez, G.; Vasadia, D.;
Popuri, C.; Zhao, C.-G. Org. Lett. 2005, 7, 4145. (c) Chen, H.; Li, R.;
Gao, F.; Li, X. Tetrahedron Lett. 2012, 53, 7147.
Detailed experimental procedures and characterization of new
compounds. This material is available free of charge via the
(10) (a) Shibatomi, K.; Soga, Y.; Narayama, A.; Fujisawa, I.; Iwasa, S. J.
Am. Chem. Soc. 2012, 134, 9836. (b) Liu, L.; Rozenman, M.; Breslow, R.
Bioorg. Med. Chem. 2002, 10, 3973.
AUTHOR INFORMATION
Corresponding Authors
■
(11) (a) Fugmann, R.; Dolling, U.; Nickelsen, H. Angew. Chem., Int. Ed.
̈
1967, 6, 733. (b) Ye, T.; McKervey, M. A. Chem. Rev. 1994, 94, 1091.
(12) Kulkarni, S. S.; Hu, X.; Manetsch, R. Chem. Commun. 2013, 49,
1193.
4050
dx.doi.org/10.1021/ol501930f | Org. Lett. 2014, 16, 4048−4051